Brand-name GLP-1 medications face supply shortages, insurance denials, and authorization delays that leave patients waiting weeks or months to start therapy
A., & Panda, M
SlowER dose escalation schedulessuch as PlexusDx microdose protocolscan further minimize initial nausea severity for sensitive individuals
Obesity is the major risk factor for OSA, primarily due to the deposition of adipose tissue in the pharyngeal walls, tongue, and abdominal cavity, which increases upper airway collapsibility and reduces lung volume during sleep, predisposing individuals to airway obstruction [11, 12]
If heart rate increases become problematic, healthcare providers may consider slowing the titration schedule or maintaining a lower dose that provides clinical benefit with acceptable tolerability
This makes them particularly effective during life stages like postpartum or aging, when hormonal shifts can disrupt normal metabolic function. Heres how it works on a more scientific level: GLP-1 is a hormone your body already makes
